ReviewCurrent rheumatology reports2012
Reactive arthritis: developments and challenges in diagnosis and treatment.
Review in Current rheumatology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.
- The incidence of sexually acquired reactive arthritis: a systematic literature review.Clinical rheumatology · 2016Pooled it
- Article
- Albumin and Gamma-Glutamyl Transferase as Biomarkers for Differentiating Systemic Juvenile Idiopathic Arthritis from Reactive Arthritis.Journal of inflammation research · 2025Article
- Treatment of reactive arthritis with biological agents: a review.Bioscience reports · 2020Review
- Detection of Shigella spp. nucleic acids in the synovial tissue of Tunisian rheumatoid arthritis patients and other forms of arthritis by quantitative real-time polymerase chain reaction.Rheumatology international · 2018Article
- A rare cause of oligoarthritis with septic presentation.BMJ case reports · 2018Article
- The Case of Reactive Arthritis Secondary toCase reports in rheumatology · 2017Article
- Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats.Frontiers in immunology · 2017Article
- [Update on reactive arthritis].Zeitschrift fur Rheumatologie · 2016Review
- Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research.Current rheumatology reports · 2016Review
- The Etiology of Juvenile Idiopathic Arthritis.Clinical reviews in allergy & immunology · 2015Review
- Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.Nature reviews. Rheumatology · 2014Review
- Article
- Can rheumatoid arthritis be prevented?Best practice & research. Clinical rheumatology · 2013Review
- Selected reaction monitoring to differentiate and relatively quantitate isomers of sulfated and unsulfated core 1 O-glycans from salivary MUC7 protein in rheumatoid arthritis.Molecular & cellular proteomics : MCP · 2013Article
- The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption.Clinical & developmental immunology · 2013Review
- Reactive arthritis associated withTropical parasitologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive arthritis (ReA) has traditionally been described as a nonseptic arthritis occurring in the joint following an extra-articular bacterial infection. This concept became clinically associated with antecedent infections of either the gastrointestinal or genitourinary tract. Yet this operational definition of ReA has led to diagnostic uncertainty in different clinical settings. There are several scenarios in which the ReA has been complex. One is in the SAPHO syndrome, which shares many features with ReA. Another is the development of arthritis after infection with atypical organisms such as Clostridium difficile and Giardia lamblia. Treatment of ReA remains an area of ongoing investigation. There has been a randomized controlled trial of combination antibiotics in Chlamydia-induced ReA, which reported a positive result. There are several uncontrolled reports of anti-TNF agents being used successfully in refractory ReA. These studies in treatment modalities require validation on larger samples but do provide some encouraging preliminary findings from which to develop new therapeutic approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.